Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling

9 Jun 2016

Abstract excerpt

Pancreatic adenocarcinoma (PDAC) is known to have a poor prognosis partly because of lack of effective biomarkers. In the test set, we investigated dysbindin (DTNBP1) as a potential biomarker for PDAC by comparing preoperative and postoperative serum mass spectrometry (MS) proteomic profilings. Of the included 50 PDAC patients, 42 (positivity of 84.0%) detected a lower MS peak in postoperative serums than...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to FOXO transcription factor regulation
Share to Pancreatic function and diabetes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27281120
DOI: 10.1002/ijc.30227

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profilingPMID 27281120Read ↗

Mass spectrometry-based proteomic analysis of PDAC samplesSemantic proximity Read ↗

Proteome alterations in pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

SWATH-MS based proteomic profiling of Pancreatic Ductal Adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathwaysSemantic proximity Read ↗

SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways.Semantic proximity Read ↗

Targeted and Explorative Profiling of Kallikrein Proteases and Global Proteome Biology of Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Normal Pancreas Highlights Disease-Specific Proteome RemodellingSemantic proximity Read ↗

Current State of “Omics” Biomarkers in Pancreatic CancerSemantic proximity Read ↗

Molecular assessment of endoscopically collected pancreatic juice and duodenal fluid from patients with pancreatic diseases.Semantic proximity Read ↗

Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational scienceSemantic proximity Read ↗

Integrated proteomics and phosphoproteomics reveal perturbed regulative pathways in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

The Mutant p53-Driven Secretome Has Oncogenic Functions in Pancreatic Ductal Adenocarcinoma Cells.Semantic proximity Read ↗

Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.